Analystreport

Keryx Biopharmaceuticals (NASDAQ: KERX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

KERYX BIOPHARMACEUTICALS  (KERX) 
Last keryx biopharmaceuticals earnings: 11/8 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.keryx.com/investor-overview